CRIS Current Research Information System

MIGLIOLI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.398
NA - Nord America 3.221
EU - Europa 1.760
SA - Sud America 292
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 157
OC - Oceania 3
Totale 8.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.140
SG - Singapore 1.053
VN - Vietnam 814
CN - Cina 731
HK - Hong Kong 360
SE - Svezia 289
GB - Regno Unito 278
IT - Italia 278
BR - Brasile 235
DE - Germania 226
FR - Francia 132
RU - Federazione Russa 108
IN - India 98
IE - Irlanda 88
NL - Olanda 84
UA - Ucraina 69
JP - Giappone 67
KR - Corea 62
BG - Bulgaria 56
FI - Finlandia 45
CA - Canada 44
SC - Seychelles 44
BD - Bangladesh 42
CI - Costa d'Avorio 41
CH - Svizzera 29
AR - Argentina 28
JO - Giordania 26
TG - Togo 26
ZA - Sudafrica 25
ID - Indonesia 20
MX - Messico 19
PH - Filippine 19
PL - Polonia 18
TH - Thailandia 17
ES - Italia 13
PK - Pakistan 12
IQ - Iraq 11
IR - Iran 11
BE - Belgio 10
AT - Austria 9
EE - Estonia 9
TR - Turchia 9
EC - Ecuador 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
BH - Bahrain 6
CL - Cile 6
KE - Kenya 6
MY - Malesia 6
CO - Colombia 5
RO - Romania 5
NG - Nigeria 4
NP - Nepal 4
PY - Paraguay 4
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 8.834
Salva come PNG Salva come JPEG
Città #
Singapore 691
Hong Kong 344
San Jose 320
Ashburn 317
Chandler 287
Santa Clara 263
Ho Chi Minh City 221
Southend 203
Hanoi 187
Boardman 122
Beijing 115
Council Bluffs 107
Fairfield 104
Princeton 97
Hefei 95
Dublin 88
New York 65
Los Angeles 64
Sofia 52
Ann Arbor 51
Houston 50
Tokyo 50
Wilmington 49
Lauterbourg 47
Seoul 46
Woodbridge 46
Berlin 43
Helsinki 43
Cambridge 42
Abidjan 41
Jacksonville 41
Seattle 38
Frankfurt am Main 33
Da Nang 30
Haiphong 29
Bern 28
São Paulo 28
Guangzhou 27
Milan 27
Amman 26
Buffalo 26
Lomé 26
Bologna 25
Dong Ket 24
Falkenstein 24
Nanjing 23
Chicago 22
Dallas 22
Rome 18
Shanghai 18
Turin 18
San Francisco 17
Padova 16
Westminster 16
Orem 15
Redondo Beach 14
Warsaw 14
Montreal 13
Bengaluru 12
Columbus 12
Mumbai 12
Boston 11
Denver 11
Hải Dương 11
Brussels 10
Chennai 10
Jinan 10
London 10
Phoenix 10
Poplar 10
San Diego 10
Wuhan 10
Xi'an 10
Biên Hòa 9
Can Tho 9
Changsha 9
Düsseldorf 9
Hangzhou 9
Johannesburg 9
Mexico City 9
Naples 9
Nuremberg 9
Shijiazhuang 9
Yubileyny 9
Amsterdam 8
Atlanta 8
Bari 8
Curitiba 8
Kyiv 8
Lahore 8
Munich 8
Olalla 8
Vũng Tàu 8
Washington 8
Zhengzhou 8
Belo Horizonte 7
Mountain View 7
Mülheim 7
Nanchang 7
Salt Lake City 7
Totale 5.289
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 286
Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment 264
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 264
Erosions or not in GORD? The potential role of oesophageal cell proliferation 247
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 241
Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux 219
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 218
Diagnosi non invasiva e terapia per Helicobacter Pylori 209
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 207
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 203
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 201
Erosions or not in GERD? The potential role of esophageal cell kinetics 191
Diagnosi dell’infezione da Helicobacter pylori 181
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 180
Three-year experience in clinical intestinal transplantation 176
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 171
Peptic ulcer and Helicobacter pylori. 161
Superoxide dismutase expression in gastric adenocarcinoma: a clinical biomarker in the development of cancer. 142
Long-term efficacy of bismuth carbomer enemas in patients with treatment-resistant chronic pouchitis 124
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 123
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 111
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 111
Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis 110
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 110
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 109
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 109
Interleukin 1 in ulcerative colitis 109
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 106
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 104
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients 103
Role of rectal formulations: Enemas 102
Macrophage subpopulations in pouchitis 100
Bronchopulmonary involvement in ulcerative colitis 98
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 97
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 97
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis 95
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 95
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils 94
Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC) 93
Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis 92
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 92
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 90
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 89
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 89
Pentasa in maintenance treatment of ulcerative colitis 89
Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation 82
Rifaximin suspension for the eradication of helicobacter pylori 79
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 76
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 73
Helicobacter pylori and diminished growth in children: Is it simply a marker of deprivation? 73
Non-invasive analyses for the diagnosis of Helicobacter pylori infection. A critical review of the literature 71
Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis 68
A rapid, low-dose, 13C-urea tablet for the detection of Helicobacter pylori infection before and after treatment 64
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 64
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori 60
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 60
Peptic ulcer and Helicobacter pylori: Update on testing and treatment 58
The clinical role of cytochrome P450 genotypes in Helicobacter pylori management 57
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection 54
High eradication rates of Helicobacter pylori with a new sequential treatment 53
High eradication rates of Helicobacter pylori with a new sequential treatment 53
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 51
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 47
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 46
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 45
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia 44
Lipid peroxidation and antioxidant status in adults receiving lipid- based home parenteral nutrition 43
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 42
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 42
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 42
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 41
Review article: Diagnosis and treatment of Helicobacter: A 2002 updated review 41
Diagnostic accuracy of a new rapid urease test (Pronto Dry) before and after treatment of Helicobacter pylori infection 40
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 39
Therapeutics news on Helicobacter pylori and clarithromycin from Budapest, Wien and Helsinki 38
Review article: Helicobacter pylori infection from pathogenesis to treatment - A critical reappraisal 36
Review article: Diagnosis of Helicobacter pylori infection 35
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 34
Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects 33
Lactose Malabsorption in Adult Patients with Crohn's Disease 33
Biliary surgery without the surgeon! 32
Susceptibility of Helicobacter pylori to Metronidazole 32
Routes of trasmission of Helicobacter pylori infection 32
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment [7] 31
Clinical significance of helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors 30
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 30
Optimal nutritional indexes in gastroenterology 29
Low levels of essential fatty acids in the red blood cell membrane phospholipid fraction of long-term home parenteral nutrition patients [1] 29
Source of Helicobacter pylori Infection 28
Anti-CagA reactivity in Helicobacter pylori-negative subjects: A comparison of three different methods 27
Prospective screening of dyspeptic patients by Helicobacter pylori serology: A safe policy? 25
Symptoms and Helicobacter pylori: Any link [6] 25
Clinical role of fecal antigen determination in the diagnosis of Helicobacter pylori infection 25
Diagnosis of Helicobacter pylori infection: Which is the best test? The stool test 24
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 23
Therapeutic news on Helicobacter pylori from Budapest and Wien 22
IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients [17] 22
Helicobacter pylori and other spiral organisms in gastroduodenal disease 20
Helicobacter pylori: Diseases, tests and treatment 20
Helicobacter pylori and other spiral organisms in gastroduodenal disease 20
Totale 8.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022668 0 12 30 34 36 14 4 25 125 71 207 110
2022/20231.024 109 172 88 84 69 80 28 69 182 21 50 72
2023/2024444 96 66 30 60 32 83 12 23 3 23 7 9
2024/20251.795 59 189 131 100 402 88 130 69 27 135 55 410
2025/20263.897 296 308 344 287 404 208 279 262 844 375 142 148
2026/2027278 103 175 0 0 0 0 0 0 0 0 0 0
Totale 8.991